Clinical trial
Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in…
NCT00264004 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00264004 |
|---|---|
| Title | Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours |
| Official title | A Phase II, Randomised, Factorial, Double-blind Study to Investigate the Management of AZD2171-induced Hypertension and Efficacy of AZD2171 at Doses of 30 mg and 45 mg in Patients With Advanced Solid Tumours |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tumors |
| Intervention type | Drug |
| Interventions | AZD2171 |
| Enrollment | 119 |
| Start date | Nov 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Apr 1, 2011 |
| First posted | Dec 12, 2005 |
| Last update posted | Aug 29, 2012 |
| Countries | Germany, Netherlands, United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: